Zhejiang Huakang Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 405.4 million compared to CNY 328.67 million a year ago. Revenue was CNY 405.4 million compared to CNY 328.67 million a year ago. Net income was CNY 50.29 million compared to CNY 51.43 million a year ago. Basic earnings per share from continuing operations was CNY 0.2214 compared to CNY 0.2704 a year ago. Diluted earnings per share from continuing operations was CNY 0.2214 compared to CNY 0.2704 a year ago.